$CBIS This added capacity will allow the Company to further its drug development programs more quickly. The Company has targeted current success with a few critical ailments including Cancer, PTSD, HIV/AIDS, Autism, and Neurological disorders, utilizing and monitoring different cannabinoid formulations and delivery modules. The Company will have a much wider base to work from by expanding into the State of Nevada, drawing another very large targeted medical consumer base.
https://finance.yahoo.com/news/cannabis-scien...56707.html
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!